Table 1 patient baseline characteristics
From: Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity
site | maxillary sinus | 19 pts |
nasal cavity | 3 pts | |
ethmoid sinus | 3 pts | |
sphenoid sinus | 1 pt | |
pansinus | 3 pts | |
histology | adenoidcystic carcinoma | 20 pts |
malignant melanoma | 3 pts | |
undifferentiated carcinoma | 1 pt | |
chordoma | 1 pt | |
chondrosarcoma | 1 pt | |
osteosarcoma | 1 pt | |
ameloblastic carcinoma | 1 pt | |
malignant peripheral nerve sheath tumour | 1 pt | |
stage | T4 | 18 pts |
T3 | 4 pts | |
T2 | 1 pt | |
N+ | 1 pt | |
not applicable | 5 pts | |
therapy | primary | 20 pts |
local relapse | 9 pts | |
reirradiation | 2 pts | |
R1-resected | 11 pts | |
R2-resected/definitive RT | 17 pts | |
orbital exenteration | 4 pts | |
post-induction | 2 pts | |
comb. Radioimmunotherapy | 1 pt |